Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells
- PMID: 26318439
- DOI: 10.1007/s11010-015-2546-4
Holothurian glycosaminoglycan inhibits metastasis via inhibition of P-selectin in B16F10 melanoma cells
Abstract
P-selectin-mediated tumor cell adhesion to platelets is a well-established stage in the process of tumor metastasis. Through computerized structural analysis, we found a marine-derived polysaccharide, holothurian glycosaminoglycan (hGAG), behaved as a ligand-competitive inhibitor of P-selectin, indicating its potential to disrupt the binding of P-selectin to cell surface receptor and activation of downstream regulators of tumor cell migration. Our experimental data demonstrated that hGAG significantly inhibited P-selectin-mediated adhesion of tumor cells to platelets and tumor cell migration in vitro and reduced subsequent pulmonary metastasis in vivo. Furthermore, abrogation of the P-selectin-mediated adhesion of tumor cells led to down-regulation of protein levels of integrins, FAK and MMP-2/9 in B16F10 cells, which is a crucial molecular mechanism of hGAG to inhibit tumor metastasis. In conclusion, hGAG has emerged as a novel anti-cancer agent via blocking P-selectin-mediated malignant events of tumor metastasis.
Keywords: Holothurian glycosaminoglycan; Melanoma; P-Selectin.
Similar articles
-
Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.J Vasc Res. 2015;52(3):197-209. doi: 10.1159/000439220. Epub 2015 Oct 22. J Vasc Res. 2015. PMID: 26488158
-
Acidic mucopolysaccharide from Holothuria leucospilota has antitumor effect by inhibiting angiogenesis and tumor cell invasion in vivo and in vitro.Cancer Biol Ther. 2009 Aug;8(15):1489-99. doi: 10.4161/cbt.8.15.8948. Epub 2009 Aug 8. Cancer Biol Ther. 2009. PMID: 19483477
-
Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor-κB/tissue factor/Factor Xa pathway in melanoma B16F10 cells.PLoS One. 2013;8(2):e56557. doi: 10.1371/journal.pone.0056557. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437168 Free PMC article.
-
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.Cancer Res. 1996 Dec 1;56(23):5309-18. Cancer Res. 1996. PMID: 8968075 Review.
-
The use of novel antineoplastic agents to inhibit the growth and metastasis of malignant melanoma and other cancers.Pigment Cell Res. 1992;Suppl 2:219-33. doi: 10.1111/j.1600-0749.1990.tb00376.x. Pigment Cell Res. 1992. PMID: 1409424 Review. No abstract available.
Cited by
-
Effects of Holothurian Glycosaminoglycan on the Sensitivity of Lung Cancer to Chemotherapy.Integr Cancer Ther. 2020 Jan-Dec;19:1534735420911430. doi: 10.1177/1534735420911430. Integr Cancer Ther. 2020. PMID: 32202167 Free PMC article.
-
Targeting Selectins and Their Ligands in Cancer.Front Oncol. 2016 Apr 18;6:93. doi: 10.3389/fonc.2016.00093. eCollection 2016. Front Oncol. 2016. PMID: 27148485 Free PMC article. Review.
-
Pharmacological Potential of Sea Cucumbers.Int J Mol Sci. 2018 May 2;19(5):1342. doi: 10.3390/ijms19051342. Int J Mol Sci. 2018. PMID: 29724051 Free PMC article. Review.
-
Immunoenhancement Effects of Glycosaminoglycan from Apostichopus japonicus: In Vitro and In Cyclophosphamide-Induced Immunosuppressed Mice Studies.Mar Drugs. 2017 Nov 7;15(11):347. doi: 10.3390/md15110347. Mar Drugs. 2017. PMID: 29112115 Free PMC article.
-
Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.Int J Mol Sci. 2018 Jun 6;19(6):1690. doi: 10.3390/ijms19061690. Int J Mol Sci. 2018. PMID: 29882812 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous